These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3081907)

  • 1. Early transmembrane events in alloimmune cytotoxic T-lymphocyte activation as revealed by stopped-flow fluorometry.
    Utsunomiya N; Tsuboi M; Nakanishi M
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1877-80. PubMed ID: 3081907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 2 increases T lymphocyte membrane mobility before the rise in cytosolic calcium concentration.
    Utsunomiya N; Tsuboi M; Nakanishi M
    Biochemistry; 1986 May; 25(9):2582-4. PubMed ID: 3013307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serine protease triggers the initial step of transmembrane signalling in cytotoxic T cells.
    Utsunomiya N; Nakanishi M
    J Biol Chem; 1986 Dec; 261(35):16514-7. PubMed ID: 3536928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early transmembrane events in tumour cell responses observed by stopped-flow fluorometry.
    Utsunomiya N; Tsuboi M; Nakanishi M
    FEBS Lett; 1985 Aug; 187(2):245-8. PubMed ID: 4018262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.
    Bevan MJ; Langman RE; Cohn M
    Eur J Immunol; 1976 Mar; 6(3):150-6. PubMed ID: 62665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil inhibition of lymphocyte proliferation and function in vitro.
    McMillen MA; Lewis T; Jaffe BM; Wait RB
    J Surg Res; 1985 Jul; 39(1):76-80. PubMed ID: 3159937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P815 mastocytoma cells, classical targets for cytotoxic T lymphocytes, exert natural cytotoxicity.
    Luciani MF; Brunet JF; Denizot F; Golstein P
    Ann Inst Pasteur Immunol; 1987; 138(1):37-43. PubMed ID: 3107589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of cytotoxic T lymphocyte activity by time-resolved fluorometry using europium-labelled concanavalin A-stimulated cells as targets.
    Granberg C; Blomberg K; Hemmilä I; Lövgren T
    J Immunol Methods; 1988 Nov; 114(1-2):191-5. PubMed ID: 2972782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for CD28-dependent T cell-mediated cytotoxicity.
    Azuma M; Cayabyab M; Phillips JH; Lanier LL
    J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell recognition of cloned HLA class I gene products expressed on DNA transfectants of mouse mastocytoma P815.
    Maryanski JL; Moretta A; Jordan B; De Plaen E; Van Pel A; Boon T; Cerottini JC
    Eur J Immunol; 1985 Nov; 15(11):1111-7. PubMed ID: 2933264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor.
    Wilson A; Shortman K
    Eur J Immunol; 1985 Sep; 15(9):899-905. PubMed ID: 2412835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a T-lymphocyte membrane protein involved in T-cell function: its contribution to T-cell recognition or cellular interaction.
    Schrod L; Schaefer H; Burger R
    Immunology; 1986 Apr; 57(4):533-8. PubMed ID: 3485568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites.
    Ksander BR; Streilein JW
    J Immunol; 1989 Jul; 143(2):426-31. PubMed ID: 2500481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca
    Frick M; Mouchacca P; Verdeil G; Hamon Y; Billaudeau C; Buferne M; Fallet M; Auphan-Anezin N; Schmitt-Verhulst AM; Boyer C
    Immunology; 2017 Feb; 150(2):199-212. PubMed ID: 27716898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of lymphocyte signal transduction by murine mastocytoma ascites.
    Ding L; Isobe K; Yoshida T; Nakashima I
    Microbiol Immunol; 1991; 35(9):767-74. PubMed ID: 1808472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.